切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Pyruvate dehydrogenases (PDH) - MARK1 - PTK - Sir2-like Family Deacetylases (Sirtuins)

11件产品中的 1-10

页面
每页
清除全部
  1. Inauhzin
    B3272 Inauhzin
    Target: Sir2-like Family Deacetylases (Sirtuins)
    Summary: SIRT1抑制剂
      ≥23.5 mg/mL
      insoluble in H2O
  2. FG2216
    B5851 FG2216
    Target: Pyruvate dehydrogenases (PDH)
    Summary: HIF-脯氨酰羟化酶抑制剂
      ≥14.05 mg/mL
      insoluble in H2O
  3. Tenovin-6
    A8302 Tenovin-6
    Target: Sir2-like Family Deacetylases (Sirtuins)
    Summary: SIRT抑制剂,p53激活剂
      ≥22.75 mg/mL
      insoluble in H2O
  4. Butein
    A2689 Butein
    中文名: 紫铆因,紫铆查尔酮
    Target: Src|STAT|EGFR|Angiotensin-Converting Enzymes (ACEs)|5-Lipoxygenases|PTK|enoyl-acyl-carrier protein reductase
    Summary: 蛋白激酶抑制剂
      ≥13.6 mg/mL
      insoluble in H2O
  5. Genistein
    A2198 Genistein
    中文名: 金雀异黄酮,染料木素
    Target: Estrogen and Related Receptors|PPAR|PTK
    Summary: ER agonist
      ≥13.5 mg/mL
      insoluble in H2O
  6. SRT2104 (GSK2245840)
    A3821 SRT2104 (GSK2245840)
     1 Citation
    Target: Sir2-like Family Deacetylases (Sirtuins)
    Summary: SIRT1激活剂
      ≥6.46 mg/mL
      insoluble in H2O
  7. MRT67307 HCl
    A3635 MRT67307 HCl
    Target: TBK1|MARK1|NUAK1
    Summary: SIK/TBK-1/IKKe抑制剂
      ≥23.25 mg/mL
      ≥52.5 mg/mL
  8. CPI-613
    A4333 CPI-613
     1 Citation
    Target: Pyruvate dehydrogenases (PDH)
    Summary: PDH/α-KGDH抑制剂
      ≥19.45 mg/mL
      insoluble in H2O
  9. Tenovin-1
    A4203 Tenovin-1
    Target: Sir2-like Family Deacetylases (Sirtuins)|p53|p21
    Summary: SIRT2 抑制剂,p53激活剂
      ≥15 mg/mL
      insoluble in H2O
  10. Resveratrol
    A4182 Resveratrol
     2 Citation
    中文名: 白藜芦醇
    Target: Sir2-like Family Deacetylases (Sirtuins)|COX|LOX|Adenylyl cyclase|Quinone reductase
    Summary: SIRT1激活剂
      ≥9.65 mg/mL
      insoluble in H2O

11件产品中的 1-10

页面
每页